News

Back

Novasep and Handl Therapeutics announce signature of a gene therapy product development and manufacturing agreement

November 2nd 2020

BioPark

This agreement covers the development and manufacturing of an Adeno-Associated Virus (AAV) based gene therapy drug candidate for the treatment of neurodegenerative diseases.  Discover the press release here.